Veillette, A. (2006) Immunol. Rev. 214:22. Bottino, C. et al. (2001) J. Exp. Med. 194:235. Fraser, C.C. et al. (2002) Immunogenetics 53:843. Eissmann, P. and C. Watzl (2006) J. Immunol. 177:3170.
NTB-A (NK-T-B-antigen), also known as Ly108 and SLAMF6, is a 60 kDa type I transmembrane glycoprotein that belongs to the SLAM subgroup of the CD2 family. Mature human NTB-A contains a 205 amino acid (aa) extracellular domain (ECD) with one Ig-like V-set and one Ig-like C2-set domain. It also contains a 21 aa transmembrane segment and an 84 aa cytoplasmic domain with two immunoreceptor tyrosine-based switch motifs (ITSMs). An alternately spliced isoform is truncated in the cytoplasmic domain and lacks the two ITSMs. NTB-A functions as an activating coreceptor on NK and T cells. Tyrosine phosphorylation in the membrane proximal ITSM enables specific association with EAT-2, an interaction that is required for NTB-A mediated cytotoxicity of NK cells.
1μg (R: reducing condition, N: non-reducing condition).